Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons
Stereological Quantification of Immune-Competent Cells in Biopsies From Painful Achilles Tendons of Psoriatic Arthritis Patients With Ultrasonic Verified Enthesitis: An Exploratory Prospective Cohort Study
Odense University Hospital
30 participants
Aug 21, 2017
OBSERVATIONAL
Conditions
Summary
Tendon pathologies (enthesitis) are a characteristic component of psoriatic arthritis (PsA), and are observed in 35% to 50% of PsA patients. The Achilles tendon is one of the most commonly affected sites. This condition often causes great morbidity and loss of quality of life, and response only suboptimal to current intervention strategies. One of the main obstacles for the development of effective treatment methods is that the disease mechanisms remain poorly understood. To our knowledge, no one has yet ascertained the presence and function of immune-competent cells and inflammatory markers in tendons tissue from PsA patients suffering from Achilles enthesitis.
Eligibility
Inclusion Criteria3
- Fulfilling the CASPAR criteria
- Insertional Achilles tendon pain
- Ultrasonic findings of inflammatory disease at the painful Achilles tendon insertion (= enthesitis) defined as abnormally hypoechoic (loss of normal fibrillar architecture) and/or thickened tendon at its bony attachment, seen in two perpendicular planes that may exhibit a Doppler signal or bony changes, including enthesophytes, and erosions.
Exclusion Criteria3
- Other inflammatory rheumatic diseases than PsA
- Ultrasonic signs of complete rupture of the Achilles tendon
- Not wishing to participate or not suited for project evaluation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Two tendon biopsy specimens will be obtained from one Achilles tendon with enthesitis.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03248284